In this study, we assessed the expression of Skp1 in non-small cell lung cancers (NSCLCs), and screened for Skp1 inhibitors in a total of 21,008 compounds by structure-based high-throughput virtual screening. The gene discussed is SKP1; the disease is non-small cell lung carcinoma.